PubMed Health⌕ Search

PubMed · 12766284

[X-ray exposure dose control for x-ray CT system].

Abstract

Shortening scan time of CT scanner system has been evolved and increase in number of CT examinations has also been remarkable. This has been resulted from global recognition of usefulness of the CT examination, contrary to this merit, however, it is important to recognize the risk of x-ray exposure dose. Japan Industry Association of Radiological Systems (JIRA) in which CT manufacturers join has issued the concrete countermeasure and guidance for reduction in x-ray exposure dose in response to the ICRP90 Recommendation. Current CT scanner systems provide the data related to x-ray exposure dose such as CTDI(w) for setting CT scan parameters. To reduce x-ray exposure dose against infant patient, the scan parameters specified to infant patient (CT infant protocol) can be provided. Exposure dose by x-ray CT can be measured by the measurement method corresponding to IEC-60601-2-44 and by using phantom. CTDI measurement is made by CTDI(100) that measures in a range of 100mm for all slice thicknesses, and absorbed radiation dose is converted to that of air. Dose profile is measured by using multiple thermoluminescence dosimeter (TDL) chips. CT exposure dose data including CTDI(100) and Dose profile are well-defined, and Dose Information Guide conforming to IEC-60601-2-44 is provided to user for the purpose of reducing x-ray exposure dose. Studies by low dose (2.5 approximately 3mA) simulation for the purpose of reducing x-ray exposure dose in screening CT examination of lung cancer and development of ROI scan to reduce x-ray exposure dose in puncture under CT fluoroscopy have also been conducted.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hiroshi Takagi. 2002. [X-ray exposure dose control for x-ray CT system].. https://pubmed.ncbi.nlm.nih.gov/12766284/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗